Download PDF Genes and Common Diseases by Alan Wright and Nicholas Hastie



Sinopsis

The completion of the human genome project has heralded a new era in biology. Undoubtedly, knowledge of the genetic blueprint will expedite the search for genes responsible for specific medical disorders, simplify the search for mammalian homologues of crucial genes in other biological systems and assist in the prediction of the variety of gene products found in each cell. It can also assist in determining the small but potentially significant genetic variations between individuals. However, sequence information alone is of limited value without a description of the function and, importantly, of the regulation of the gene products. Our bodies consist of hundreds of different cell types, each designed to perform a specific role that contributes to the overall functioning of the organism. Every one of these cells contains the same 20 000 to 30 000 genes that we are estimated to possess. The remarkable diversity in cell specialization is achieved through the tightly controlled expression and regulation of a precise subset of these genes in each cell lineage. Further regulation of these gene products is required in the response of our cells to physiological and environmental cues. Most impressive perhaps is how a tightly controlled program of gene expression guides the development of a fertilised oocyte into a full-grown adult organism. The human genome has been called our genetic blueprint, but it is the process of gene expression that truly brings the genome to life. In this chapter we aim to provide a general overview of the physical appearance of genes and the mechanisms of their expression.


The realization that certain traits are inherited from our ancestors must have been around for ages, but the study of these hereditary traits was first established by the Austrian monk Gregor Mendel. In his monastery in Brno, Czechoslovakia, he performed his famous experiments crossing pea plants and following a number of hereditary traits. He realised that many of these traits were under the control of two distinct factors, one
coming from the male parent and one from the female. He also noted that the traits he studied were not linked and thus must have resided on separate hereditary units, now known as chromosomes, and that some appearances of a trait could be dominant over others. In the early 1900s, with the rediscovery of Mendel’s work, the factors conveying hereditary traits were named ‘‘genes’’ by Wilhelm Johanssen. A large amount of
research since then has led to our current understanding about what constitutes a gene and how genes work.

Genes can be defined in two different ways: the gene as a ‘‘unit of inheritance’’, or the gene as a physical entity with a fixed position on the chromosome that can be mapped in relation to other genes (the genomic locus). While the latter is the more traditional view of a gene the former view is more suited to our current understanding of the genomic architecture of genes. A gene gives rise to a phenotype through its ability to generate an RNA (ribonucleic acid) or protein product. Thus the functional genetic unit must encompass not
only the DNA (deoxyribonucleic acid) that is transcribed into RNA, but also all of the surrounding DNA sequences that are involved in its transcription. Those regulatory sequences are called the cis-regulatory elements, and contain the binding sites for trans-acting transcription factors. Cis-regulatory elements can be grouped into different classes which will be discussed in more detail later. Recently it has become recognized
that cis-regulatory elements can be located anywhere on the chromosomal segment surrounding the gene from next to the promoter to many hundreds of kilobases away, either upstream or downstream. Notably, they can also be found in introns of neighboring genes or in the intergenic region beyond the next gene. Crucially, the concept of a gene as a functional genetic unit allows genes to overlap physically yet remain isolated from one another if they bind different sets of transcription factors (Dillon, 2003). As more genes are characterized in greater detail, it is becoming clear that overlap of functional genetic units is a widespread phenomenon.



Content

  1. Genes and their expression
  2. Epigenetic modification of chromatin
  3. Population genetics and disease
  4. Mapping common disease genes
  5. Population diversity, genomes and disease
  6. Study design in mapping complex disease traits
  7. Diseases of protein misfolding
  8. Aging and disease
  9. The MHC paradigm: genetic variation and complex disease
  10. Lessons from single gene disorders
  11. Common Medical Disorders
  12. Developmental disorders
  13. Genes, environment and cancer
  14. The polygenic basis of breast cancer
  15. TP53: A master gene in normal and tumor suppression
  16. Genetics of colorectal cancer
  17. Genetics of autoimmune disease
  18. Susceptibility to infectious diseases
  19. Inflammatory bowel diseases
  20. Genetic anemias
  21. Genetics of chronic disease: obesity
  22. Type 2 diabetes mellitus
  23. Genetics of coronary heart disease
  24. Genetics of hypertension
  25. Obstructive pulmonary disease
  26. Skeletal disorders
  27. The genetics of common skin diseases
  28. Molecular genetics of Alzheimer’s disease and other adult-onset dementias
  29. Major psychiatric disorders in adult life
  30. Speech and language disorders
  31. Common forms of visual handicap
  32. Genetic and environmental influences on hearing impairment
  33. Pharmacogenomics: clinical applications




Download PDF Concepts Of Genetics by Robert J. Brooker


Sinopsis

Hardly a week goes by without a major news story involving a genetic breakthrough. The increasing pace of genetic discoveries has become staggering. The Human Genome Project is a case in point. This project began in the United States in 1990, when the National Institutes of Health and the Department of Energy joined forces with international partners to decipher the massive amount of information contained in our genome the deoxyribonucleic acid (DNA) found within all of our chromosomes (Figure 1.1 ). Working collectively, a large group of scientists from around the world produced a detailed series of maps that help geneticists navigate through human DNA. Remarkably, in only a decade, they determined the DNA sequence covering over 90% of the human genome. The first draft of this sequence, published in 2001, was nearly 3 billion nucleotide base pairs in length. The completed sequence, published in 2003, has an accuracy greater than 99.99%; fewer than one mistake was made in every 10,000 base pairs (bp)! Studying the human genome allows us to explore fundamental details about ourselves at the molecular level. The results of the Human Genome Project are expected to shed considerable light on basic questions, such as how many genes we have, how genes direct the activities of living cells, how species evolve, how single cells develop into complex tissues, and how defective genes cause disease. Furthermore, such understanding may lend itself to improvements in modern medicine by providing better diagnoses of diseases and the development of new treatments for them.

As scientists have attempted to unravel the mysteries within our genes, this journey has involved the invention of many new technologies. This textbook emphasizes a large number of these modern approaches. For example, new technologies have made it possible to produce medicines that would otherwise be difficult or impossible to make. An example is human recombinant insulin, sold under the brand name Humulin, which is synthesized in strains of Escherichia coli bacteria that have been genetically altered by the addition of genes that encode the functional regions of human insulin. The bacteria are grown in a laboratory and make large amounts of human insulin, which is purified and administered to millions of people with insulin-dependent diabetes. Chapter 20 describes the production of insulin in greater detail and also examines other ways that genetic approaches have applications in the area of biotechnology.

New genetic technologies are often met with skepticism and sometimes even with disdain. An example is DNA fingerprinting, a molecular method for identifying an individual based on a DNA sample (see Chapter 25 ). Though this technology is now relatively common in the area of forensic science, it was not always universally accepted. High-profile crime cases in the news cause us to realize that not everyone accepts the accuracy of DNA fingerprinting, in spite of its extraordinary ability to uniquely identify individuals.

A second controversial example is mammalian cloning. In 1997, Ian Wilmut and his colleagues produced clones of sheep, using mammary cells from an adult animal (Figure 1.2 ). More recently, such cloning has been achieved in several mammalian species, including cows, mice, goats, pigs, and cats. In 2002, the first pet was cloned, a cat named Carbon copy, or Copycat (see photo at the beginning of the chapter). The cloning of mammals provides the potential for many practical applications. Cloning of livestock would enable farmers to use cells from their best individuals to create genetically homogeneous herds. This could be advantageous in terms of agricultural yield, although such a genetically homogeneous herd may be more susceptible to certain diseases. However, people have become greatly concerned with the possibility of human cloning. As discussed in Chapter 20 , this prospect has raised serious ethical questions. Within the past few years, legislative bills have been introduced that involve bans on human cloning.

Finally, genetic technologies provide the means of modifying the traits of animals and plants in ways that would have been unimaginable just a few decades ago. Figure 1.3a illustrates a bizarre example in which scientists introduced a gene from jellyfish into mice. Certain species of jellyfish emit a “green glow” produced by a gene that encodes a bioluminescent protein called green fluorescent protein (GFP). When exposed to blue or ultraviolet (UV) light, the protein emits a striking green-colored light. Scientists were able to clone the GFP gene from a sample of jellyfish cells and then introduce this gene into laboratory mice. The green fluorescent protein is made throughout the cells of their bodies. As a result, their skin, eyes, and organs give off an eerie green glow when exposed to UV light. Only their fur does not glow.

The expression of green fluorescent protein allows researchers to identify particular proteins in cells or specific body parts. For example, Andrea Crisanti and colleagues have altered mosquitoes to express GFP only in the gonads of males (Figure 1.3b). This enables the researchers to identify and sort males from females. Why is this useful? The ability to rapidly sort mosquitoes by sex makes it possible to produce populations of sterile males and then release the sterile males without the risk of releasing additional females. The release of sterile males may be an effective means of controlling mosquito populations because females breed only once before they die. Mating with a sterile male prevents a female from producing offspring. In 2008, Osamu Shimomura, Martin Chalfie, and Roger Tsien received the Nobel Prize in chemistry for the discovery and the development of GFP, which has become a widely used tool in biology. Overall, as we move forward in the twenty-first century, the excitement level in the field of genetics is high, perhaps higher than it has ever been. Nevertheless, the excitement generated by new genetic knowledge and technologies will also create many ethical and societal challenges. In this chapter, we begin with an overview of genetics and then explore the various fields of genetics and their experimental approaches.


Content

  1. Reproduction and Chromosome Transmission
  2. Mendelian Inheritance 
  3. Sex Determination and Sex Chromosomes 
  4. Extensions of Mendelian Inheritance 
  5.  Extranuclear Inheritance, Imprinting, and Maternal Effect 
  6. Genetic Linkage and Mapping in Eukaryotes 
  7. Variation in Chromosome Structure and Number 
  8. Genetics of Bacteria 
  9. Genetics of Viruses
  10. Molecular Structure of DNA and RNA 
  11. Molecular Structure and Organization of Chromosomes 
  12. DNA Replication and Recombination
  13. Gene Transcription and RNA Modification 
  14. Translation of mRNA 
  15. Gene Regulation in Bacteria 
  16. Gene Regulation in Eukaryotes 
  17. Gene Mutation and DNA Repair
  18. Recombinant DNA Technology 
  19.  Biotechnology 
  20. Genomics I: Analysis of DNA and Transposable Elements 
  21. Genomics II: Functional Genomics, Proteomics, and Bioinformatics 
  22. Medical Genetics and Cancer 
  23. Developmental Genetics and Immunogenetics 
  24. Population Genetics 
  25. Quantitative Genetics 
  26. Evolutionary Genetics



Download PDF Evolutionary Conservation Geneticsby by Jacob Höglund


Sinopsis


Extinction is a fact. Ever since organic life fi rst evolved on this planet, life forms have been changing. New species have arisen and old ones have gone extinct (Raup 1992). Speciation, the birth of new species, and extinction, the death of species, are as natural events in evolution as birth and death of individuals in demography. Seen over the entire history of organic life on Earth, biodiversity has generally increased. There has been a build up of life forms. However, five times in the evolutionary past of the planet have mass extinction events taken place. The so-called big fi ve are periods when the rate of extinction of species has become vastly elevated and have outnumbered the level of new species forming (Raup 1994). It is now established that some of the elevated levels of mass extinction coincide with major celestial impacts on the Earth’s surface and their climatic consequences, although some workers advocate more complex scenarios that include a number of factors that may explain mass extinction (Erwin 2006). Today we are witnessing a sixth major mass extinction event and this time celestial impact has nothing to do with it. It is beyond doubt that this event is caused by the activities of one of the species inhabiting the Earth: modern humans. I can think of no other scientifi c activity more important than trying to understand the causes and consequences of this contemporary mass extinction. This book is therefore concerned with a proposition put forward some years ago that extinction of species is somehow related to loss of genetic variation.

It has been suggested that genetic variation is crucial for the persistence of populations (Soulé 1980, 1986, 1987, Frankel and Soulé 1981, Gilpin and Soulé 1986). Two reasons have been given. In the short term, inbreeding and genetic drift leads to lower fi tness of individuals and increased extinction risk of populations. In the long term, populations that lose genetic variation cannot evolve since evolution cannot proceed without genetic variation. In a world of rapid environmental change, any population that is unable to adapt to changing conditions will go extinct (Spielman et al. 2004).


Content

  1. The extinction vortex, is genetic variation related to extinction?
  2. How to measure genetic variation
  3. Inbreeding, geographic subdivision, and gene flow
  4. Genetic diversity in changing environments
  5. Genes under selection: Mhc and others
  6. Local adaptation
  7. Ecological genomics
  8. An evolutionary conservation biology





Download PDF Muscle Disease: Pathology and Genetics Second Edition by HANS H. GOEBEL



Sinopsis
 
There is a very wide variety of disorders that result in muscle weakness, pain, and wasting. The causes of muscle disease range from disruption of the nerve supply and destruction of segments of muscle fi bers to interference with the function of individual enzymes or proteins within fi bers that characterizes genetic disorders of muscle. Appropriate management and treatment of muscle disease entail close collaboration between clinicians, pathologists, and geneticists, although the balance of involvement of the three groups may vary depending upon the nature of the disease. In adults, muscle diseases are often due to denervation or inflammation as in polymyositis, dermatomyositis, and inclusion body myositis, or to toxic and drug-related myopathies and the effects of aging. However, there is also a growing number of recognized inherited muscle disorders of adult onset. The picture is rather different in children, in whom genetic disorders predominate. During the last two decades, there has been an explosion of research into genetic disorders of muscle and this has changed the way in which clinicians and researchers view muscle disease and challenged the traditional classifi cation of muscle disease. The aim of this book is to review the whole range of muscle disease using the motor unit and the subcellular components of the muscle fi ber to guide the reader through the many different disorders. The concept behind the book is that clinicians, pathologists, and geneticists require an understanding of each other ’ s disciplines to communicate effectively in the quest for diagnosis and appropriate management and treatment of the patient. In some cases, the diagnosis may be obvious from the clinical presentation and from relatively noninvasive investigations such as electromyography (EMG), magnetic resonance imaging (MRI), and measurements of enzymes such as creatine kinase in the blood. Other cases of muscle disease require muscle biopsy to confirm, pathologically, the presence of denervation, an infl ammatory disorder or a reaction to a drug. In a growing number of cases, a muscle biopsy is required to identify the presence of abnormal structures and/or abnormalities in protein expression which, when correlated with clinical features, can aid the identifi cation of a gene defect. This last pathway to diagnosis is often complicated as a defect in one gene may result in a spectrum of phenotypes, or in different phenotypes and pathologies that may overlap with more than one disorder. On the other hand, defects in several different genes may produce similar clinical phenotypes and pathologies. It is the role of this book to set out the pathology and genetics of muscle disease in such a manner that it will guide clinicians, pathologists, and geneticists through the complicated maze of our current understanding of muscle disorders.


Content

  1. Assessment of Muscle Disease
  2. Neurogenic Muscle Disease
  3. Diseases of Neuromuscular Transmission
  4. Sarcolemma: Muscular Dystrophies and Related Disorders
  5. Disorders of Nuclear Proteins and Nuclear Positioning
  6. Early- and Late-Onset Disorders of Myofibrils
  7. Disorders Associated with Intermediate Filaments
  8. Mitochondria
  9. Sarcoplasmic Reticulum and T-tubules
  10. Cytoplasmic Proteins
  11. Metabolic and Storage Disorders
  12. Muscle Diseases with DNA Expansions
  13. Facioscapulohumeral Dystrophy
  14. Inflammatory Myopathies
  15. Toxic Myopathies
  16. Aging and Systemic Disease
  17. Rare Structural Abnormalities

Download BRS Biochemistry, Molecular Biology, and Genetics Fifth Edition by Todd A. Swanson



Content

  1. PROTEIN STRUCTURE AND FUNCTION
  2. ENZYMES
  3. BIOCHEMISTRY OF DIGESTION
  4. GLYCOLYSIS
  5. THE TRICARBOXYLIC ACID CYCLE, ELECTRON TRANSPORT CHAIN, AND OXIDATIVE METABOLISM
  6. GLYCOGEN METABOLISM
  7. GLUCONEOGENESIS AND THE MAINTENANCE OF BLOOD GLUCOSE LEVELS
  8. MISCELLANEOUS CARBOHYDRATE METABOLISM
  9. FATTY ACID METABOLISM
  10. CHOLESTEROL METABOLISM AND BLOOD LIPOPROTEINS
  11. KETONES AND OTHER LIPID DERIVATIVES
  12. AMINO ACID METABOLISM
  13. PRODUCTS DERIVED FROM AMINO ACIDS
  14. NUCLEOTIDE AND PORPHYRIN METABOLISM
  15. INTEGRATIVE METABOLISM AND NUTRITION
  16. MOLECULAR ENDOCRINOLOGY
  17. DNA REPLICATION AND TRANSCRIPTION
  18. RNA TRANSLATION AND PROTEIN SYNTHESIS
  19. GENETICS
  20. BIOCHEMISTRY OF CANCER
  21. TECHNIQUES IN BIOCHEMISTRY, MOLECULAR BIOLOGY, AND GENETICS